As soon as the grey cast iron hardened in its mould at Volvo’s Skövde foundry, the brick of still-hot metal was lifted with pliers, placed in a fireproof steel box filled with sand, and loaded into a car. Within hours, it would be sliced, and studied at MAX IV’s ForMAX beamline.
New views of complex biological tissue with fourth generation light
A group of Danish researchers have demonstrated three-dimensional sub-micrometre imaging of a whole, multi-millimetre sized, mantis shrimp eye. The eye was chosen to show the imaging opportunities of highly complex biological tissue at a fourth generation synchrotron.
The Experimental Safety Risk Assessment (ESRA) form moves from the DOMNI-portal to DUO
We are making it easier to complete your Experimental Safety Risk Assessment form. The ESRA form will be available directly in DUO, creating a smoother and more integrated experience for all MAX IV users.
New insights into how nanoparticles move in swirling flows
It’s a morning routine: pour milk into coffee and watch the liquids come together in swirls. The pattern is familiar, but the behavioural patterns driving these swirls are hidden from coffee drinkers.
Children in need inspire a snake antivenom like no other
When venomous snakes in sub-Saharan Africa strike at rural residents, antivenom treatment may come too late or lack efficacy. An international team of scientists took on the challenge to create a more effective medicine for snakebites, and after many years, developed a powerful, broad spectrum nanobody cocktail which both neutralizes the venom in the bloodstream and prevents local tissue damage. Their study reported in Nature includes data from MAX IV’s BioMAX beamline.
MAX IV launched new virtual tour for curious minds
MAX IV now opens its doors 24/7, 365 days a year, virtually! Come experience the MAX IV universe and the high-tech research infrastructure. The virtual tour is available on MAX IV web.
From experiment to insight: connecting three national research infrastructures
MAX IV, NAISS and InfraVis are combining data generation, high-performance computing and advanced visualization in a unique collaboration. By connecting their complementary capabilities, the three national research infrastructures strengthen Swedish research and enable more efficient use of national investments.
Accelerating cancer drug discovery at BioMAX
Supported by advanced structural biology capabilities at MAX IV, Acrivon Therapeutics advanced a novel cancer drug candidate from initial lead identification to clinical development in only 15 months.
X-ray study gives clues to earlier osteoarthritis detection
Osteoarthritis is a painful, sometimes disabling and irreversible condition that affects many people. A recent study by researchers from Lund, Sweden and Switzerland confirms that X-ray imaging is an important tool for developing indicators that could aid early detection to slow progression.
Pilot reimbursement program for Swedish users
Starting with the Fall26 user cycle, users with a Swedish affiliation outside Skåne will, under certain circumstances, be able to apply for financial compensation for travel and sample shipping. This opportunity is a pilot project for fall 2026 to be evaluated and developed before the first user cycle of 2027. How to apply More information